CLABSI


Also found in: Acronyms.

CLABSI

central line-associated bloodstream infection.
References in periodicals archive ?
"Our findings suggest that current NHSN definitions may not sufficiently account for increased CLABSI risk at institutions that perform high-intensity care," the authors write.
The study also found the reduction in CLABSI rates was associated with an estimated cost savings of $4,070 to $39,600 per 1,000 catheter days.
There were nine patients classified as CLABSI who were neutropenic; in three of these the CVC was not removed.
The centers for disease control and prevention (CDC) estimated that, in 2002, 250,000 central line associated blood stream infections (CLABSIs) occurred in US hospitals, accounting for >30,000 deaths4.
The significant burden of CLABSI in neonates suggests that prevention is vital to the reduction of morbidity, mortality, and financial burden.
[1] Central-line-associated bloodstream infections (CLABSI) are a type of device-associated HAI mainly encountered in the ICU setting.
The group is currently working with data elements related to CLABSI (peripheral and central lines), with a goal of coding them to LOINC and SNOMED CT in 2017.
The only prospective clinical HAI surveillance at TCH has been conducted by neonatal ICU staff since 2013, reporting central line-associated bloodstream infection (CLABSI) rates (a type of device-associated HAI accounting for just 1.5% of paediatric HAI at our institution).
Descriptive statistics and t test results for lab units per patient day, case mix index, safety measures, and outcome measures for the preintervention and postintervention periods Pre--post 95% CI for mean Outcomes Mean SD difference R t df UPPD 0.48 0.46 0.13, 0.83 0.93 * 3.18 * 8 CMI -0.03 0.09 -0.09, 0.04 0.75 * -0.96 8 Vent wean 0.06 0.12 -0.04, 0.15 0.65 1.40 8 Readmissions -0.01 0.03 -0.03, 0.02 0.86 * -0.48 8 Central lines 0.02 0.12 -0.07, 0.11 -0.13 0.51 8 CLABSI 0.40 0.60 -0.06, 0.86 -0.11 -1.99 8 MRSA -0.14 0.27 -0.34, 0.07 0.55 -1.53 8 Other MDRO -0.09 0.40 -0.40, 0.22 0.90 * -0.66 8 * P< 0.05.
The following were tracked: resistant organisms, possible ventilator-associated pneumonia (VAP), central line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI).